Cytokinetics Inc. (CYTK)
Last updated: 2026-11-19 02:45:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Cytokinetics Inc. (CYTK) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $51.33, with a market capitalization of $7.41B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $50.98 to $88.31. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$7.41B | |
$51.48 | |
$53.03 | |
$50.98 | |
$51.65 | |
1.27M | |
2.02M | |
-- | |
$88.31 | |
$50.98 | |
-- | |
2026-09-30 |
Cytokinetics Inc. (CYTK) Latest Closing Stock Price
Cytokinetics Inc. (CYTK) last closed at $51.33 as of 2026-11-19 00:31:00, down 0.56% ($0.29) from the previous close of $51.65.
During the latest regular trading session, CYTK traded between $50.98 and $53.03, with a volume of 1.27M shares. The closing price was near the lower end and near the lower end of its 52-week range.
Cytokinetics Inc. (CYTK) 7-Day Stock Price Change
Over the past seven days, Cytokinetics Inc. (CYTK) moved from $55.14 to $51.33, representing a decline of 6.91% ($3.81).
The stock traded between $50.98 and $59.08 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 2.25 million shares, down versus the previous seven-day period, indicating lower trading activity.
CYTK 52-Week Price Position
Position in Range: 0.9%
CYTK is currently trading at $51.33, placing it 0.9% of the way from its 52-week low of $50.98 to its 52-week high of $88.31. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Cytokinetics Inc. (CYTK)?
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Cytokinetics Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 673 |
| Exchange | NASDAQ |
| Company Website |
CYTK News
Latest news related to Cytokinetics Inc. and CYTK stock.
- Read Full Article
- Read Full Article
Cytokinetics Announces Prescribing Information for MYQORZO® (aficamten) Expanded to Include Data from Phase 3 MAPLE-HCM
The FDA approved an updated prescribing label for Cytokinetics' MYQORZO (aficamten), a cardiac myosin inhibitor for obstructive hypertrophic cardiomyopathy (oHCM), to include Phase 3 MAPLE-HCM trial data comparing it to the beta-blocker metoprolol. MYQORZO demonstrated significantly greater improvements in exercise capacity, symptom burden, and cardiac biomarkers compared to metoprolol, making it the only cardiac myosin inhibitor with such comparative evidence in its U.S. label.
Ways to Trade CYTK at MEXC
How to Buy Cytokinetics Inc. (CYTK) Stock on MEXC
Eligible investors can buy real shares of Cytokinetics Inc. (CYTK) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Cytokinetics Inc. (CYTK) stock price today?
2.Is CYTK stock going up or down today?
3.What is CYTK pre-market price?
4.What is CYTK after-hours price?
5.Is CYTK stock trading now?
6.Where does CYTK sit relative to its 52-week high and low?
7.What sector is Cytokinetics Inc. in?
8.What is Cytokinetics Inc.'s market capitalization and where is it listed?
9.How is CYTK valued in terms of P/E ratio and EPS?
10.Does Cytokinetics Inc. pay a dividend?
Explore More US Stocks
Compliance Disclosure and Data Source
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to CYTK, including Stocks, Tokenized Stocks, and Stock Futures.
Disclaimer
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Search Stocks
CYTK Stock Calculator
Estimate the value between CYTK shares and USD.
CYTK Shares to USD
1.00 CYTK shares = 51.328 USD
Calculations are estimates based on the latest available price and are for reference only.


